Frightening" Resistant Clostridial Myonecrosis: A Case Report | Canada Hyperbarics Skip to main content
Case Report Cureus 2019

Frightening" Resistant Clostridial Myonecrosis: A Case Report

Hassan S, Akhtar A, Khan M, Sheikh F, Asghar H — Cureus, 2019

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers described the case of a 17-year-old female who developed severe clostridial myonecrosis in her arm after an injury, which did not improve with standard antibiotic treatment.

What They Found

A 17-year-old patient developed clostridial myonecrosis in her left arm following a fall, initially misdiagnosed as a fracture. Despite receiving broad-spectrum antibiotics including intravenous benzylpenicillin, rifampicin, and clindamycin for a considerable period, her condition worsened, and the infection continued to spread. This progression ultimately led to the need for intervention with hyperbaric oxygen therapy.

Canadian Relevance

The study authors are not Canadian. No direct Canadian connection identified.

Study Limitations

As a case report, this study describes the experience of a single patient, meaning its findings cannot be broadly applied to all individuals with clostridial myonecrosis.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Infection
Source Pubmed
PubMed ID 31263647
Year Published 2019
Journal Cureus

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 16, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology